Czech Republic - Medicinal products and medical devices - Medicinal product containing the active substance OZANIMOD

The contracting authority in the Czech Republic is procuring a medicinal product containing the active substance ozanimod. The subject of the tender is the conclusion of a framework purchase agreement for the supply of medicinal products according to the needs of the contracting authority. The buyer is a Czech contracting authority, and the place of delivery is the Czech Republic. Supplies will be ordered as needed under the framework agreement. Economic operators interested in supplying the medicinal product may participate in the tender procedure, subject to the conditions set out in the tender documents.

Description

35 open tenders right now

• Medicinal products and medical devices - Medicinal product with active substance ERDAFITINIB 28 Sep 2026 · 2 days left
• Czech Republic - Medicinal products and medical devices - Medicinal products with active substance USTEKINUMAB II. 28 Sep 2026 · 2 days left
• Medicinal products and medical devices - Medicinal product with active substance MOMELOTINIB 28 Sep 2026 · 2 days left

Recent awards

• Česko - Léčivé přípravky a zdravotnické prostředky - Dodávky léčivých přípravků s účinnou látkou Brodalumab

  awarded to Alliance Healthcare s.r.o. €767,543

• Česko - Léčivé přípravky a zdravotnické prostředky - Léčivý přípravek s účinnou látkou AFLIBERCEPT

  awarded to BAYER s.r.o. €1,419,506

• Česko - Opravy a údržba zdravotnických přístrojů - Servisní služby na produkty výrobce Maquet a Getinge

  awarded to Getinge Czech Republic, s.r.o. €141,943

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€10,070,574

9,859 open across Europe right now 75% below sector average

Buyer track record on Aperlena

455 notices tracked · 161 awarded

€340,824,584 in awarded contracts